Compare EZGO & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EZGO | CTSO |
|---|---|---|
| Founded | 2014 | 1997 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Motor Vehicles | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.4M | 26.5M |
| IPO Year | 2020 | 2008 |
| Metric | EZGO | CTSO |
|---|---|---|
| Price | $1.25 | $0.52 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | ★ 4.6M | 139.2K |
| Earning Date | 07-01-2025 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 65.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $22,503,908.00 |
| Revenue This Year | N/A | $10.34 |
| Revenue Next Year | N/A | $22.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 48.53 |
| 52 Week Low | $0.01 | $0.37 |
| 52 Week High | $3.30 | $1.39 |
| Indicator | EZGO | CTSO |
|---|---|---|
| Relative Strength Index (RSI) | 48.06 | 51.73 |
| Support Level | $0.10 | $0.47 |
| Resistance Level | $1.32 | $0.72 |
| Average True Range (ATR) | 0.34 | 0.06 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 6.42 | 51.89 |
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.